Clinical Trials
6 trialsNCT06751524 2026-05-15
Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval
Agenus Inc.
Available
NCT05398640 2026-04-20
Expanded Access Program of AMTAGVI That is Out of Specification for Commercial Release
Iovance Biotherapeutics, Inc.
Available
NCT04566393 2026-01-28
Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies
xCures
Available
NCT06063746 2026-01-08
Compassionate Use of Vidutolimod
Regeneron Pharmaceuticals
No longer available
NCT04489433 2025-12-18
Compassionate Use Program to Access Trametinib and Dabrafenib for Patients With BRAF Mutation-positive Metastatic Melanoma
Novartis
No longer available
NCT06590480 2025-12-18
RPL-EAP-001
Replimune, Inc.
No longer available